CTTI is pleased to welcome its newest members. CTTI actively engages all stakeholders equally to collaboratively improve the quality and efficiency of the clinical trials enterprise. These organizations bring diverse viewpoints to help CTTI develop solutions with real-world impact.

• Alpha-1 Foundation: nonprofit promoting research for Alpha-1 Antitrypsin Deficiency
• Amici Clinical Research: clinical research center in New Jersey associated with a family practice treating 15,000 active patients.
• Boehringer Ingelheim: global, research-driven pharmaceutical company.
• Cystic Fibrosis Foundation: nonprofit and world leader in the search for a cure for cystic fibrosis.
• inVentiv Health: global provider of healthcare & pharma consulting to biopharmaceutical clients.
• Novartis: global healthcare company that provides solutions to address the evolving needs of patients worldwide.

CTTI now has more than 80 member organizations and several individual patient/caregiver representatives. Learn more about our diverse membership.